← Back to Search

Exercise for Pediatric Cancer

N/A
Recruiting
Led By Jamie Mochel, MSN, CPNP-AC
Research Sponsored by Jamie Mochel
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 2-25 at time of consent
Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
Must not have
Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion
Osteosarcoma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 month period
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if there are benefits to exercise for people newly diagnosed with cancer.

Who is the study for?
This trial is for children and young adults aged 2-25 who have been newly diagnosed with blood or solid tumor cancers, excluding osteosarcoma and primary CNS tumors. Participants must be starting or undergoing cancer treatment expected to last at least 3 months, able to understand English or Spanish, and capable of following the study's procedures.
What is being tested?
The trial is testing two exercise programs: a standard care routine versus a 'Just Move' regimen. It aims to determine if structured physical activity can provide physical and emotional benefits during cancer treatment for pediatric patients.
What are the potential side effects?
While specific side effects are not detailed for exercise interventions, participants may experience general fatigue or discomfort associated with increased physical activity. Any significant health risks will be assessed by investigators based on individual conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 2 and 25 years old.
Select...
I (or my parent/guardian) can read and understand English or Spanish.
Select...
I have been recently diagnosed with cancer and plan to start chemotherapy.
Select...
I am expected to undergo cancer treatment for at least 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had or will have surgery soon that limits my movement significantly.
Select...
I have been diagnosed with osteosarcoma.
Select...
My cancer originated in the brain or spinal cord.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment
Secondary study objectives
Adverse Event Rate
Adverse Events Related to Exercise Program
Quality of Life measured by the PedsQL Cancer Module
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: SOC EXERExperimental Treatment1 Intervention
Standard of Care Exercise
Group II: EXERExperimental Treatment1 Intervention
"Just Move" exercises

Find a Location

Who is running the clinical trial?

Jamie MochelLead Sponsor
Atrium Health Levine Cancer InstituteOTHER
26 Previous Clinical Trials
3,603 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,395 Previous Clinical Trials
2,460,145 Total Patients Enrolled

Media Library

Standard of Care Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05058508 — N/A
Pediatric Cancer Research Study Groups: EXER, SOC EXER
Pediatric Cancer Clinical Trial 2023: Standard of Care Exercise Highlights & Side Effects. Trial Name: NCT05058508 — N/A
Standard of Care Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05058508 — N/A
~33 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top